Results 91 to 100 of about 8,911,089 (208)

Perioperative Risk of Noncardiac Surgery in Patients With Asymptomatic Significant Aortic Stenosis: A 10‐Year Retrospective Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Aortic stenosis (AS) is a representative geriatric disease, and there is an anticipated rise in the number of patients requiring noncardiac surgeries in patients with AS.
Minjung Bak, Seung‐Hwa Lee, Sung‐Ji Park, Jungchan Park, Jihoon Kim, Darae Kim, Eun Kyoung Kim, Sung‐A Chang, Sang‐Chol Lee, Seung Woo Park   +9 more
doaj   +1 more source

Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction

Heart and Mind, 2018
Background: Patients with diabetes are reported having inadequate response to clopidogrel treatment compared with patients without diabetes. The present study aims to investigate the effect of clopidogrel treatment in lowering in-hospital major adverse ...
Wuxiang Xie, Lin Feng, Xian Li, Runlin Gao, Yangfeng Wu   +4 more
doaj   +1 more source

Development and validation of a new predictive model for in-hospital postoperative major adverse cardiovascular and cerebrovascular events after general anesthesia in nonagenarians undergoing non-cardiac surgery

Frontiers in Cardiovascular Medicine
BackgroundMajor adverse cardiac and cerebrovascular events (MACCE) following noncardiac surgery are the main cause of perioperative mortality. However, there are few evidence-based prediction models available for predicting the risk of MACCE. We aimed to
Lan Feng, Xuemei Tan, Xiaoxia Duan, Jiang Zheng, Xiaohui Du, Hong Fu, Yu Ma   +6 more
doaj   +1 more source

Automated prediction of major adverse cardiovascular events

Prédiction automatique des épisodes cardio-vasculaires adverses majeurs Dans ce projet de recherche financé en contrat CIFRE avec GE Healthcare, on cherche a prédire les épisodes cardio-vasculaire adverses majeurs (ECAM), c’est à dire typiquement les embolies et les anévrismes dans l’aorte et les artères coronaires, qui donnent lieu a ...
openaire   +2 more sources

Risk of major adverse cardiovascular events in treatment-resistant or severe depression

Journal of Affective Disorders
Depression is associated with higher risk of major adverse cardiovascular events (MACE). Whether patients with treatment-resistant depression (TRD) or severe depression have an even higher risk is uncertain.Patients 18-75 years old with a depressive episode in specialized psychiatric care were identified using national Swedish registers.
Adam, Nygren, Johan, Reutfors, Pär, Karlsson, Mikael, Tiger, Jonas, Faxén, Philip, Brenner   +5 more
openaire   +2 more sources

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

, 2018
Major adverse cardiovascular events in non‐valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS ...
Daniele Pastori, Stefania Basili, Puato M, Marco Proietti, Giovanni Davì, Francesco Violi, Gino Roberto Corazza, Roberto Cangemi, Gregory Yoke Hong Lip, null null, ...., William Robert Hiatt, Francesco Perticone, et al, Anna Rita Vestri, Valeria Raparelli, Pasquale Pignatelli, Serena Francesca Pignataro   +17 more
core   +1 more source

Microbiota γ‐Butyrobetaine Is Associated With Increased Risk of Major Adverse Limb Events in People With Lower Extremity Arterial Disease Undergoing Endovascular Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Peripheral artery disease (PAD), a significant contributor to both acute and chronic illnesses, indicates a grave prognosis, but it is often unrecognized and receives inadequate treatment.
Zheng‐Wei Chen, Wei‐Kai Wu, Jiun‐Yang Chiang, Nai‐Chen Cheng, Jen‐Kuang Lee, Ming‐Shiang Wu   +5 more
doaj   +1 more source

One-year major adverse cardiovascular events and secondary prevention targets in standard care vs. ELIPS add-on groups.

, 2019
One-year major adverse cardiovascular events and secondary prevention targets in standard care vs. ELIPS add-on groups.
Sebastian Carballo (531090), Francois Mach (6387641), Baris Gencer (543628), Reto Auer (543627), Dik Heg (201287), David Nanchen (299982), Olivier Muller (701042), Pierre-Frédéric Keller (531092), Roland Klingenberg (126166), Thomas F. Lüscher (126194), Lorenz Räber (543629), Christian M. Matter (239126), Stephan Windecker (95664), Peter Jüni (50488), David Carballo (531091), Nicolas Rodondi (174911)   +15 more
core   +1 more source

Apolipoprotein B100 predicts cardiovascular and limb events in type 2 diabetes patients with chronic limb-threatening ischemia

Cardiovascular Diabetology
Background Patients with type 2 diabetes mellitus (T2DM) and chronic limb-threatening ischemia (CLTI) undergoing lower extremity revascularization (LER) face high risks of major adverse cardiovascular events (MACE) and major adverse limb events (MALE ...
Federico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex   +10 more
doaj   +1 more source

Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes & Metabolism
Background Chronic kidney disease (CKD) affects over half a billion people globally and significantly increases the risk of cardiovascular complications, particularly in those with type 2 diabetes mellitus (T2DM).
Ali Abdullah, F. N. U. Sagreeka, Gurdas Alias Aniket, Rohan Lal, F. N. U. Geeta, Anusha Bai, Ghazi Uddin Ahmed, Ahmed Asad Raza, Varisha Fatima Shaikh, Owais Sanaullah, Syeda Elezeh Sabahat, Ahzam Khan Ghori, Seema Habib Bhutto, Mahir Tesfaye   +13 more
doaj   +1 more source